Training Details

Event Dates and Timeframe Any Time

Location

Online Webinar
8005480497
naadac@naadac.org

Cost Range

FREE to $35.00 (depending on options)

Host and Instructor

Host: National Association for Alcoholism and Drug Abuse Counselors (NAADAC)
Instructor: Mita M. Johnson, EdD, LPC, LMFT, LAC, MAC, SAP

Credits

C.E. Credit for NAADAC - The Association for Addiction Professionals: 1.50
If you have watched the webinar (either live or on-demand), you are eligible to receive a Certificate of Completion to verify the continuing education hours you spent learning. To apply (only after watching the webinar), complete and pass the online CE Quiz at the top of this page. NAADAC members receive a CE certificate for 1.5 CEs for free.
C.E. Credit for NAADAC - The Association for Addiction Professionals: 3.00
If you have watched the webinar (either live or on-demand), you are eligible to receive a Certificate of Completion to verify the continuing education hours you spent learning. To apply (only after watching the webinar), complete and pass the online CE Quiz at the top of this page. Non-members of NAADAC can receive 3 CEs for $35.

Description

This is a three part webinar series that has been made available as an anytime training.

Addiction counselors and allied service providers have an ethical obligation to protect their clients, their communities, and themselves through infection and disease containment. In addition, all National Certification Commission for Addiction Professionals (NCC AP) national credentials require at least six hours of HIV/Bloodborne Pathogens-specific education.



Section 2: Human Immunodeficiency Virus
Originally Aired on October 31, 2018

Clients who are exposed to infected blood are at high risk for contracting HIV. HIV is a chronic illness in need of lifelong treatment engagement. This section of the webinar will define key terms used when discussing HIV and AIDS and disease transmission. The primary actions of current medications will be explained. Questions will be provided that can help the clinician assess risk. Cultural implications of engagement and treatment will be explored. Current testing procedures will be explored.